Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Prostate Cancer

  Free Subscription

Articles published in PLoS Med

Retrieve available abstracts of 7 articles:
HTML format

Single Articles

    March 2024
  1. CUI H, Zhang W, Zhang L, Qu Y, et al
    Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses.
    PLoS Med. 2024;21:e1004362.
    PubMed     Abstract available

    February 2024
  2. SELLEM L, Srour B, Javaux G, Chazelas E, et al
    Food additive emulsifiers and cancer risk: Results from the French prospective NutriNet-Sante cohort.
    PLoS Med. 2024;21:e1004338.
    PubMed     Abstract available

    January 2023
  3. FANG S, Yarmolinsky J, Gill D, Bull CJ, et al
    Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.
    PLoS Med. 2023;20:e1003988.
    PubMed     Abstract available

    June 2022
  4. PARKER CC, James ND, Brawley CD, Clarke NW, et al
    Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
    PLoS Med. 2022;19:e1003998.
    PubMed     Abstract available

    January 2022
  5. IOANNIDOU A, Watts EL, Perez-Cornago A, Platz EA, et al
    The relationship between lipoprotein A and other lipids with prostate cancer risk: A multivariable Mendelian randomisation study.
    PLoS Med. 2022;19:e1003859.
    PubMed     Abstract available

    June 2021
  6. XU X, Kharazmi E, Tian Y, Mukama T, et al
    Risk of prostate cancer in relatives of prostate cancer patients in Sweden: A nationwide cohort study.
    PLoS Med. 2021;18:e1003616.
    PubMed     Abstract available

    May 2021
  7. TIERNEY JF, Fisher DJ, Vale CL, Burdett S, et al
    A framework for prospective, adaptive meta-analysis (FAME) of aggregate data from randomised trials.
    PLoS Med. 2021;18:e1003629.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.